NEW! Cost Savings Calculator

See how much you could save by prescribing Trustsaver® products

MyriBase™ Gel

(ingredients include isopropyl myristate 15% w/w and liquid paraffin 15% w/w)

20% savings with MyriBase™ Gel vs Doublebase™ Gel*1

Contact us today
MyriBase™ Gel

At-a-glance

  • An emollient gel to help prevent dry skin conditions, such as eczema, contact dermatitis, psoriasis, ichthyosis and pruritus2

  • Suitable for all ages including children2

  • High-quality formulation and packaging to maximise patient acceptance

  • Can deliver significant budget savings vs. Doublebase™ Gel1

  • Available in a 500ml airless pump to reduce waste2

Request Free Samples

Compare the quality of MyriBase™ Gel with your currently used products.

Contact us today

Like for like versus Doublebase™ Gel2,3

Make significant acquisition cost savings vs. Doublebase™ Gel by prescribing MyriBase™ Gel by brand1

Get personalised savings
Assumptions and Calculations References
Assumptions and Calculations

  • Percentage savings with MyriBase™ Gel are calculated based on MIMS list prices.1

  • The NHS list price of MyriBase™ Gel is £4.66 per 500ml pump, and the NHS list price of Doublebase™ Gel is £5.83 per 500g pump.1

References

  1. MIMS online. Accessed May 2020.

  2. MyriBase™ Gel Instructions for Use. December 2019.

  3. Doublebase™ Gel Summary of Product Characteristics. December 2019.

*Per available equivalent pack size (100g and 500g/ml).
Doublebase™ Gel is a registered trademark of Dermal Laboratories Limited.
MyriBase™ Gel is a registered trademark of Penlan Healthcare Limited.

Request personalised potential savings

Provide a few quick details and we'll get back to you with the savings your organisation could make with Trustsaver®

Galen will not share your email address with any third parties. By requesting information you are under no obligation to meet with a Galen representative. By submitting your information you acknowledge that you have read the Galen privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to customer.services@galen-pharma.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.

By using this website, you agree to the use of cookies as described in our Privacy Policy.

Accept

Designed to help prescribing budgets go further

I am a Healthcare Professional
I am a Patient
The Trustsaver® portfolio of products includes:
  • Dermipar® Ointment (ingredients include white soft paraffin, liquid paraffin, cetomacrogol emulsifying wax)
  • ExoCream® (ingredients include white soft paraffin 14.5% w/w, liquid paraffin 12.6% w/w and anhydrous lanolin 1.0% w/w)
  • Laxido® Orange (macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride)
  • Laxido® Paediatric Plain (macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride)
  • Miclaro™ Oat Cream (ingredients include avena sativa kernel flour 1% w/w)
  • Miclaro™ Oat Lotion (ingredients include avena sativa kernel flour 1% w/w)
  • MyriBase™ Emollient Shower Gel (ingredients include isopropyl myristate 15% w/w and liquid paraffin 15% w/w)
  • MyriBase™ Gel (ingredients include isopropyl myristate 15% w/w and liquid paraffin 15% w/w)
  • Rapilose® Gel (glucose gel 40% w/w)
  • Salivix® Plus (ingredients include malic acid and sodium fluoride)
  • Salivix® Spray (ingredients include malic acid, xylitol and sodium fluoride)
  • Thorens® 10,000 I.U./ml oral drops, solution (colecalciferol)
  • Thorens® 25,000 I.U./2.5ml oral solution (colecalciferol)
  • Zemtard® XL (diltiazem hydrochloride)

Patient Information

Galen Limited is a privately-owned pharmaceutical sales and marketing company established in 1968. By combining innovation in product development with competitive pricing, Galen aims to work in partnership with healthcare professionals and patients, a major factor in the company's success to date. If you would like to find out more about Galen, its products or information on the disease areas we cover, please visit www.galen-pharma.com.